
You can purchase shares of DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC (OTCQB:DTCFF) through any online brokerage.
There are no as such competitors for DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC.
There is no analysis for DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC to provide a consensus price target.
The stock price for DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC (OTCQB: DTCFF) is $0.2761 last updated October 23, 2026 at 11:53 AM EDT.
There are no upcoming dividends for DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC.
DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC does not have any upcoming earnings scheduled.
There is no upcoming split for DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC.
DEFENCE THERAPEUTICS A by DEFENCE THERAPEUTICS INC is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.
Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases....